175 related articles for article (PubMed ID: 25042852)
1. Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditions.
Wen J; Tao W; Kuiatse I; Lin P; Feng Y; Jones RJ; Orlowski RZ; Zu Y
Int J Cancer; 2015 Mar; 136(5):991-1002. PubMed ID: 25042852
[TBL] [Abstract][Full Text] [Related]
2. Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors.
Ikegame A; Ozaki S; Tsuji D; Harada T; Fujii S; Nakamura S; Miki H; Nakano A; Kagawa K; Takeuchi K; Abe M; Watanabe K; Hiasa M; Kimura N; Kikuchi Y; Sakamoto A; Habu K; Endo M; Itoh K; Yamada-Okabe H; Matsumoto T
Leukemia; 2012 Sep; 26(9):2124-34. PubMed ID: 22430632
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the characteristics of side population cells in the human ovarian cancer cell line OVCAR-3].
Luo LJ; Zhao Z; Zeng JF; Liang B; Yang JX; Cao DY; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):281-5. PubMed ID: 22781115
[TBL] [Abstract][Full Text] [Related]
4. URI regulates tumorigenicity and chemotherapeutic resistance of multiple myeloma by modulating IL-6 transcription.
Fan JL; Zhang J; Dong LW; Fu WJ; Du J; Shi HG; Jiang H; Ye F; Xi H; Zhang CY; Hou J; Wang HY
Cell Death Dis; 2014 Mar; 5(3):e1126. PubMed ID: 24625985
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib reduces the tumorigenicity of multiple myeloma via downregulation of upregulated targets in clonogenic side population cells.
Nara M; Teshima K; Watanabe A; Ito M; Iwamoto K; Kitabayashi A; Kume M; Hatano Y; Takahashi N; Iida S; Sawada K; Tagawa H
PLoS One; 2013; 8(3):e56954. PubMed ID: 23469177
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma.
Du J; Liu S; He J; Liu X; Qu Y; Yan W; Fan J; Li R; Xi H; Fu W; Zhang C; Yang J; Hou J
Oncotarget; 2015 Jun; 6(17):14993-5007. PubMed ID: 25915427
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of cancer stem cell-like side population cells in human laryngeal cancer.
Yu D; Jin C; Liu Y; Yang J; Zhao Y; Wang H; Zhao X; Cheng J; Liu X; Liu C
Tumour Biol; 2013 Dec; 34(6):3603-10. PubMed ID: 23807678
[TBL] [Abstract][Full Text] [Related]
8. Identification of cancer stem-like side population cells in purified primary cultured human laryngeal squamous cell carcinoma epithelia.
Wu CP; Zhou L; Xie M; Du HD; Tian J; Sun S; Li JY
PLoS One; 2013; 8(6):e65750. PubMed ID: 23776540
[TBL] [Abstract][Full Text] [Related]
9. MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells.
Yin B; Zeng Y; Liu G; Wang X; Wang P; Song Y
Int J Clin Exp Pathol; 2014; 7(6):2934-41. PubMed ID: 25031712
[TBL] [Abstract][Full Text] [Related]
10. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
Yang Q; Li K; Li X; Liu J
Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
[No Abstract] [Full Text] [Related]
11. Biologic characteristics of the side population of human small cell lung cancer cell line H446.
Wang B; Yang H; Huang YZ; Yan RH; Liu FJ; Zhang JN
Chin J Cancer; 2010 Mar; 29(3):254-60. PubMed ID: 20193106
[TBL] [Abstract][Full Text] [Related]
12. [Identification and characterization of stem cells in an ovarian cancer cell line and examination their drug resistance].
Wei Z; Wang Y; Yu X; Zhang S
Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):452-7. PubMed ID: 26311554
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells.
Kawano Y; Kikukawa Y; Fujiwara S; Wada N; Okuno Y; Mitsuya H; Hata H
Int J Oncol; 2013 Dec; 43(6):1809-16. PubMed ID: 24126540
[TBL] [Abstract][Full Text] [Related]
15. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.
Hiraga T; Ito S; Nakamura H
Oncol Rep; 2011 Jan; 25(1):289-96. PubMed ID: 21109989
[TBL] [Abstract][Full Text] [Related]
16. Side population cells isolated from KATO III human gastric cancer cell line have cancer stem cell-like characteristics.
She JJ; Zhang PG; Wang X; Che XM; Wang ZM
World J Gastroenterol; 2012 Sep; 18(33):4610-7. PubMed ID: 22969237
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma.
Nakagawa M; Fujita S; Katsumoto T; Yamagata K; Ogawara Y; Hattori A; Kagiyama Y; Honma D; Araki K; Inoue T; Kato A; Inaki K; Wada C; Ono Y; Yamamoto M; Miura O; Nakashima Y; Kitabayashi I
Cancer Sci; 2019 Jan; 110(1):194-208. PubMed ID: 30343511
[TBL] [Abstract][Full Text] [Related]
18. Clonogenic multiple myeloma cells have shared stemness signature associated with patient survival.
Reghunathan R; Bi C; Liu SC; Loong KT; Chung TH; Huang G; Chng WJ
Oncotarget; 2013 Aug; 4(8):1230-40. PubMed ID: 23985559
[TBL] [Abstract][Full Text] [Related]
19. Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway.
He W; Fu Y; Zheng Y; Wang X; Liu B; Zeng J
BMC Cancer; 2021 Feb; 21(1):125. PubMed ID: 33549034
[TBL] [Abstract][Full Text] [Related]
20. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]